TBB6_HUMAN - dbPTM
TBB6_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID TBB6_HUMAN
UniProt AC Q9BUF5
Protein Name Tubulin beta-6 chain
Gene Name TUBB6
Organism Homo sapiens (Human).
Sequence Length 446
Subcellular Localization Cytoplasm, cytoskeleton.
Protein Description Tubulin is the major constituent of microtubules. It binds two moles of GTP, one at an exchangeable site on the beta chain and one at a non-exchangeable site on the alpha chain..
Protein Sequence MREIVHIQAGQCGNQIGTKFWEVISDEHGIDPAGGYVGDSALQLERINVYYNESSSQKYVPRAALVDLEPGTMDSVRSGPFGQLFRPDNFIFGQTGAGNNWAKGHYTEGAELVDAVLDVVRKECEHCDCLQGFQLTHSLGGGTGSGMGTLLISKIREEFPDRIMNTFSVMPSPKVSDTVVEPYNATLSVHQLVENTDETYCIDNEALYDICFRTLKLTTPTYGDLNHLVSATMSGVTTSLRFPGQLNADLRKLAVNMVPFPRLHFFMPGFAPLTSRGSQQYRALTVPELTQQMFDARNMMAACDPRHGRYLTVATVFRGPMSMKEVDEQMLAIQSKNSSYFVEWIPNNVKVAVCDIPPRGLKMASTFIGNSTAIQELFKRISEQFSAMFRRKAFLHWFTGEGMDEMEFTEAESNMNDLVSEYQQYQDATANDGEEAFEDEEEEIDG
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
36PhosphorylationGIDPAGGYVGDSALQ
CCCCCCCCCCCCHHE
10.5918452278
40PhosphorylationAGGYVGDSALQLERI
CCCCCCCCHHEEEEE
25.5818452278
50PhosphorylationQLERINVYYNESSSQ
EEEEEEEEECCCCCC
8.9728152594
51PhosphorylationLERINVYYNESSSQK
EEEEEEEECCCCCCC
14.2625348954
54PhosphorylationINVYYNESSSQKYVP
EEEEECCCCCCCCCC
31.4828152594
55PhosphorylationNVYYNESSSQKYVPR
EEEECCCCCCCCCCC
30.5228152594
56PhosphorylationVYYNESSSQKYVPRA
EEECCCCCCCCCCCE
39.7117525332
58UbiquitinationYNESSSQKYVPRAAL
ECCCCCCCCCCCEEE
50.6021890473
58AcetylationYNESSSQKYVPRAAL
ECCCCCCCCCCCEEE
50.6026051181
59PhosphorylationNESSSQKYVPRAALV
CCCCCCCCCCCEEEE
14.1930174305
72PhosphorylationLVDLEPGTMDSVRSG
EEECCCCCCCCCCCC
28.6424275569
73SulfoxidationVDLEPGTMDSVRSGP
EECCCCCCCCCCCCC
4.4830846556
75PhosphorylationLEPGTMDSVRSGPFG
CCCCCCCCCCCCCCC
14.4928857561
106PhosphorylationNNWAKGHYTEGAELV
CCCCCCCCCCHHHHH
18.3720873877
107PhosphorylationNWAKGHYTEGAELVD
CCCCCCCCCHHHHHH
23.4420873877
136PhosphorylationCLQGFQLTHSLGGGT
CCCCEEEEECCCCCC
9.91-
138PhosphorylationQGFQLTHSLGGGTGS
CCEEEEECCCCCCCC
24.3925627689
143PhosphorylationTHSLGGGTGSGMGTL
EECCCCCCCCCHHHH
31.30-
145PhosphorylationSLGGGTGSGMGTLLI
CCCCCCCCCHHHHHH
25.99-
147SulfoxidationGGGTGSGMGTLLISK
CCCCCCCHHHHHHHH
3.8730846556
149PhosphorylationGTGSGMGTLLISKIR
CCCCCHHHHHHHHHH
14.97-
153PhosphorylationGMGTLLISKIREEFP
CHHHHHHHHHHHHCC
23.23-
154UbiquitinationMGTLLISKIREEFPD
HHHHHHHHHHHHCCC
38.50-
166PhosphorylationFPDRIMNTFSVMPSP
CCCHHHHHCCCCCCC
10.4120068231
168PhosphorylationDRIMNTFSVMPSPKV
CHHHHHCCCCCCCCC
18.5720068231
172PhosphorylationNTFSVMPSPKVSDTV
HHCCCCCCCCCCCCE
21.1829978859
176PhosphorylationVMPSPKVSDTVVEPY
CCCCCCCCCCEEECC
33.4226074081
183PhosphorylationSDTVVEPYNATLSVH
CCCEEECCCCEEEHH
12.1525884760
196PhosphorylationVHQLVENTDETYCID
HHHHHCCCCCEEEEC
23.00-
199PhosphorylationLVENTDETYCIDNEA
HHCCCCCEEEECHHH
26.88-
200PhosphorylationVENTDETYCIDNEAL
HCCCCCEEEECHHHH
5.83-
208PhosphorylationCIDNEALYDICFRTL
EECHHHHHHHHHHEE
15.4325884760
216UbiquitinationDICFRTLKLTTPTYG
HHHHHEECCCCCCCH
43.08-
218PhosphorylationCFRTLKLTTPTYGDL
HHHEECCCCCCCHHH
29.19-
219PhosphorylationFRTLKLTTPTYGDLN
HHEECCCCCCCHHHH
24.8625921289
221PhosphorylationTLKLTTPTYGDLNHL
EECCCCCCCHHHHHH
37.7422817900
222PhosphorylationLKLTTPTYGDLNHLV
ECCCCCCCHHHHHHH
15.1725884760
230PhosphorylationGDLNHLVSATMSGVT
HHHHHHHHHHHCCCC
25.1218691976
232PhosphorylationLNHLVSATMSGVTTS
HHHHHHHHHCCCCCC
12.3621406692
233SulfoxidationNHLVSATMSGVTTSL
HHHHHHHHCCCCCCC
3.0830846556
234PhosphorylationHLVSATMSGVTTSLR
HHHHHHHCCCCCCCC
26.2521406692
237PhosphorylationSATMSGVTTSLRFPG
HHHHCCCCCCCCCCC
17.7521406692
238PhosphorylationATMSGVTTSLRFPGQ
HHHCCCCCCCCCCCC
24.2921406692
239PhosphorylationTMSGVTTSLRFPGQL
HHCCCCCCCCCCCCC
14.2621406692
252SumoylationQLNADLRKLAVNMVP
CCCHHHHHHHHHCCC
48.36-
252UbiquitinationQLNADLRKLAVNMVP
CCCHHHHHHHHHCCC
48.3620639865
252SumoylationQLNADLRKLAVNMVP
CCCHHHHHHHHHCCC
48.36-
267SulfoxidationFPRLHFFMPGFAPLT
CCCCCEECCCCCCCC
2.8728183972
274PhosphorylationMPGFAPLTSRGSQQY
CCCCCCCCCCCCHHH
18.4722617229
275PhosphorylationPGFAPLTSRGSQQYR
CCCCCCCCCCCHHHE
42.1822617229
276MethylationGFAPLTSRGSQQYRA
CCCCCCCCCCHHHEE
43.47-
278PhosphorylationAPLTSRGSQQYRALT
CCCCCCCCHHHEEEE
17.0122617229
281PhosphorylationTSRGSQQYRALTVPE
CCCCCHHHEEEEHHH
7.1023403867
285PhosphorylationSQQYRALTVPELTQQ
CHHHEEEEHHHHHHH
32.7929978859
290PhosphorylationALTVPELTQQMFDAR
EEEHHHHHHHHHHHH
18.3229978859
293SulfoxidationVPELTQQMFDARNMM
HHHHHHHHHHHHHHH
2.0630846556
297UbiquitinationTQQMFDARNMMAACD
HHHHHHHHHHHHHCC
33.1621890473
303S-palmitoylationARNMMAACDPRHGRY
HHHHHHHCCCCCCCE
5.5529575903
310PhosphorylationCDPRHGRYLTVATVF
CCCCCCCEEEEEEEE
16.0028152594
312PhosphorylationPRHGRYLTVATVFRG
CCCCCEEEEEEEEEC
10.1228152594
315PhosphorylationGRYLTVATVFRGPMS
CCEEEEEEEEECCCC
18.8124076635
321SulfoxidationATVFRGPMSMKEVDE
EEEEECCCCHHHHHH
7.3330846556
322PhosphorylationTVFRGPMSMKEVDEQ
EEEECCCCHHHHHHH
29.8124719451
323SulfoxidationVFRGPMSMKEVDEQM
EEECCCCHHHHHHHH
3.3130846556
324UbiquitinationFRGPMSMKEVDEQML
EECCCCHHHHHHHHH
47.4821890473
330SulfoxidationMKEVDEQMLAIQSKN
HHHHHHHHHHHHCCC
2.2830846556
335PhosphorylationEQMLAIQSKNSSYFV
HHHHHHHCCCCCCEE
27.9123911959
336UbiquitinationQMLAIQSKNSSYFVE
HHHHHHCCCCCCEEE
44.4621890473
338PhosphorylationLAIQSKNSSYFVEWI
HHHHCCCCCCEEEEC
30.1022617229
339PhosphorylationAIQSKNSSYFVEWIP
HHHCCCCCCEEEECC
31.8025159151
340PhosphorylationIQSKNSSYFVEWIPN
HHCCCCCCEEEECCC
16.0925159151
350UbiquitinationEWIPNNVKVAVCDIP
EECCCCEEEEEECCC
26.9721890473
362UbiquitinationDIPPRGLKMASTFIG
CCCCCCHHHHHHHHC
34.932190698
363SulfoxidationIPPRGLKMASTFIGN
CCCCCHHHHHHHHCC
4.2421406390
365PhosphorylationPRGLKMASTFIGNST
CCCHHHHHHHHCCCH
21.9828857561
366PhosphorylationRGLKMASTFIGNSTA
CCHHHHHHHHCCCHH
15.1028857561
371PhosphorylationASTFIGNSTAIQELF
HHHHHCCCHHHHHHH
17.6321712546
372PhosphorylationSTFIGNSTAIQELFK
HHHHCCCHHHHHHHH
31.6021712546
379UbiquitinationTAIQELFKRISEQFS
HHHHHHHHHHHHHHH
62.54-
379AcetylationTAIQELFKRISEQFS
HHHHHHHHHHHHHHH
62.5425038526
388SulfoxidationISEQFSAMFRRKAFL
HHHHHHHHHHHHHHH
2.3230846556
409PhosphorylationGMDEMEFTEAESNMN
CCCHHCCCHHHHHHH
22.4512631274
420PhosphorylationSNMNDLVSEYQQYQD
HHHHHHHHHHHHHHH
37.5712631274
422PhosphorylationMNDLVSEYQQYQDAT
HHHHHHHHHHHHHHC
8.07-
438Formation of an isopeptide bondNDGEEAFEDEEEEID
CCCHHHHHHHHHHCC
72.12-
4385-glutamyl polyglutamateNDGEEAFEDEEEEID
CCCHHHHHHHHHHCC
72.12-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
172SPhosphorylationKinaseCDK1P06493
Uniprot

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
172SPhosphorylation

16371510

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of TBB6_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
PCBP1_HUMANPCBP1physical
22863883
TBA4A_HUMANTUBA4Aphysical
22863883
TBB4B_HUMANTUBB4Bphysical
22863883

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of TBB6_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage.";
Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
Science 316:1160-1166(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-56, AND MASSSPECTROMETRY.

TOP